OAC
ZNTL icon

OMERS Administration Corp’s Zentalis Pharmaceuticals ZNTL Stock Holding History

OMERS Administration Corp’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Buy
+47,700
New +$123K ﹤0.01% 1003
2024
Q3 		– Sell
-14,500
Closed -$59.3K – 1108
2024
Q2 		$59.3K Buy
+14,500
New +$162K ﹤0.01% 959

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

OMERS Administration Corp's ZNTL Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q1 2026: 47,700 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #1003 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in ZNTL as recently as Q2 2024.

OMERS Administration Corp first reported a position in ZNTL in Q2 2024 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

  • OMERS Administration Corp held 47,700 shares of Zentalis Pharmaceuticals worth $112K as of Q1 2026.
  • Zentalis Pharmaceuticals was a new OMERS Administration Corp position in Q1 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #1003 holding.
  • OMERS Administration Corp first reported a position in Zentalis Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.